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Abstract
New developments in science are rapidly influencing and shaping basic and clinical research and
medicine. This has led to the emergence of multiple opportunities and challenges on many levels in
the bio-medical and other associated fields. To face these opportunities and challenges, new
concepts and strategies are needed. These can be provided by translational research/medicine as
an integrative concept based on a multidirectional understanding of research and medicine
embedded in a socio-economical environment. Although the implementation of translational
research/medicine faces many obstacles, some of its goals have already been part of new programs
in local institutions and in medical or scientific societies. These implementations are important in
creating a unified national and international system of translational research/medicine.
The rapid evolutions in science have generated a tremen-
dous spectrum of new technologies and tools in both
basic and clinical research/medicine. This includes the
constant improvement of old and the discovery of new
diagnostics and therapies, which increasingly contain and
integrate elements from different fields, such as biomedi-
cal and other sciences, modern and traditional medicine
and various technology branches. In addition, the appli-
cation of these developments in clinical settings have cre-
ated a "feed-back-loop" providing crucial information
about their feasibility and success in improving human
health. This network of scientific and clinical research/
medicine has become one of the factors in shaping mod-
ern societies not only by being a major economical factor
(see [1] for details), but also by challenging basic values
and traditional thinking. To face the emerging challenges
of creating a balanced and effective healthcare system,
new concepts are needed for providing a framework of
integrative strategies and solutions that efficiently com-
bine basic and clinical research/medicine.
So far, translational research/medicine has rather been a
linear concept rooted in traditional (academic)
approaches to provide therapies for diseases (from bench
to bedside), while paying little attention to patient-ori-
ented research that involves understanding the underlying
cause of disease and its treatments (from bedside to
bench). Moreover, not much attention has been paid to
many socio-economical aspects that are associated with
research or medicine. Therefore, new definitions based on
a bi- or multi-directional understanding of translational
research/medicine have been proposed [2-5] and,
recently, a strategic outline to successfully implement the
goals of this new concept has been outlined in an article
by Hörig et al. in Nature Medicine [1].
This commentary aims to add a few additional aspects by
emphasizing two major factors that strongly influence
and, in turn, are influenced by translational research/
medicine: (1) The rapid evolution of new technologies
and therapeutic approaches, and (2) examples of attempts
to create programs, which are based on a translational
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understanding of basic and clinical research and/or med-
icine.
In the past two decades, biomedical and other research
fields like gene therapy, the human genome project
(HUGO), stem cell research, cloning, nanotechnology
and others have revolutionized medicine and generated
entirely new fields and approaches in treatment of dis-
eases [6]. Thus, it is becoming more and more obvious
that new forms of therapies, such as gene- or cell-replace-
ment-therapy, will have a place in future therapeutic
approaches. In addition, the rapid expansion of bio- and
other technology development are expected to lead to an
advanced understanding of diseases [7,8]. These new
fields not only offer multiple new opportunities in the
research and biomedical sector, but also require attention
on multiple other levels involving religious and ethical
issues [9] including new definitions of life, disease, and
treatment, the power and limitations of technology, the
availability of resources, and the adjustment of social and
political actions.
How can these fields be combined and integrated in the
concept of translational research/medicine? Are there any
attempts to develop programs based on a "translational"
thinking in research and medicine? So far, the concepts of
translational research/medicine have been described and
discussed in the context of different medical fields, e.g. in
obstetrics and gynecology [10], radiation therapy and
radiobiology [11,12], cancer therapy [8], psychiatry [13],
pain research [14], gastroenterology [15] or in the broader
context of research and medicine [16]. And, so far, it
seems that there is an overall agreement in defining the
goals of translational research/medicine and delineating
the obstacles in their implementations [1,17-19]. In addi-
tion, many of these articles have provided suggestions and
strategies how to translate these concepts into practice
(e.g. [1,8,12,20-23]). However, it should be emphasized
that translational research/medicine does not affect spe-
cialized fields alone. Rather it should be an integrative
concept that, with implications to everybody in the field,
should be part of a broader understanding of how
research and medicine should be organized. A major part
of these processes refers to education and training oppor-
tunities and there have been examples published how this
can be implemented by personal experience (e.g.
[16,24]), by the quest for specialized institutions (e.g.
[20]), or by using existing educational systems (e.g. [25-
29]). It should also be noted that scientific/medical socie-
ties have started to adopt and integrate many aspects of
the concept of translational research/medicine in their
agendas and are in the process to find new creative and
innovative strategies on multiple levels, including educa-
tion, public discussions, funding opportunities, career
development, etc. This especially applies to societies,
which integrate a vast spectrum of bioresearch, biotech-
nology and biomedical fields such as the American Soci-
ety for Gene Therapy (ASGT; http://www.asgt.org) or the
International Society for Stem Cell Research (ISSCR; http:/
/www.isscr.org). On the local level, there are existing clin-
ical programs that aim to improve the clinical education
by emphasizing translational thinking (e.g. [25,27-30]) or
other programs with a broader approach of being integra-
tive between researchers, clinicians and health care pro-
viders. The latter programs – like the medical societies –
offer new opportunities to facilitate collaborations
between researchers and clinicians and represent a plat-
form to process the multilevel challenges emerging from
the rapid advances in the biomedical fields. For example,
the Harvard Medical School has launched two new cent-
ers, the Harvard Center for Neuroregeneration (HCNR;
http://www.hcnr.harvard.med.edu) and the Harvard
Stem Cell Institute (HSCI; http://stemcell.harvard.edu),
whose goals are to create an environment that combines
investigators on multiple levels and address many features
of translational research/medicine like identification of
new and alternative funding opportunities including
academia-industry synergies, healthcare delivery, the
improvement of infrastructural hurdles by creating core
facilities, training opportunities, etc. These "enterprises"
require significant logistical efforts and often rely on
established systems, which can provide, space, informat-
ics, administration, and skilled personnel. Although these
are local efforts and might not reflect the overall situation,
it shows that efforts are made and many aspects of trans-
lational research/medicine can be realized. The experi-
ences gained from these local "enterprises" might be then
translatable and integrated into a bigger national and
international network creating a more unified system of
translational research/medicine.
In summary, translational research/medicine is not a sin-
gle standing idea that can be applied whenever it is
needed. Rather, it is a concept that needs the attention
from everyone and should be the foundation of a modern
understanding of health provision. It is essential to face
the challenges emerging from the rapid advances in the
biomedical and other associated fields. Its implementa-
tion needs a multilevel effort in many different areas,
which together create a health system as a whole. Some of
the goals in translational research/medicine are already
part of new programs in local institutions and in medical
or scientific societies. These implementations are impor-
tant in creating an overall and unifying network of trans-
lational research/medicine.
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